Top Midday Gainers

MT Newswires Live12-06 02:12

Praxis Precision Medicines (PRAX) reported positive trial results late Thursday of relutrigine to treat patients with SCN2A and SCN8A developmental and epileptic encephalopathies.

Deutsche Bank adjusted its price target for Praxis shares to $303 from $270 while maintaining its buy rating.

Praxis shares soared 31% as intraday trading volume surged to over 2.2 million from a daily average of roughly 975,000.

SoftBank Group is in talks to buy private-equity firm DigitalBridge Group (DBRG), Bloomberg reported Friday, citing people with knowledge of the matter.

Shares of DigitalBridge surged 39% as intraday trading volume catapulted to over 22.4 million from a daily average of about 3.3 million.

Perceptive Capital Solutions (PCSC), a special-purpose acquisition company, and biotech firm Freenome said Friday that they have agreed to form a business combination.

The companies said the deal includes commitments from a group of healthcare investors for a $240 million common equity Private Investment in Public Equity at $10 per share.

Shares of Perceptive Capital jumped 12% as intraday trading volume climbed to nearly 2.3 million from a daily average of about 3,000.

Price: 248.34, Change: +58.37, Percent Change: +30.73

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589145988?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-06 02:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589145988","market":"hk","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PRAX\">Praxis Precision Medicines</a> (PRAX) reported positive trial results late Thursday of relutrigine to treat patients with SCN2A and SCN8A developmental and epileptic encephalopathies.</p><p>Deutsche Bank adjusted its price target for Praxis shares to $303 from $270 while maintaining its buy rating.</p><p>Praxis shares soared 31% as intraday trading volume surged to over 2.2 million from a daily average of roughly 975,000.</p><p>SoftBank Group is in talks to buy private-equity firm DigitalBridge Group (DBRG), Bloomberg reported Friday, citing people with knowledge of the matter.</p><p>Shares of DigitalBridge surged 39% as intraday trading volume catapulted to over 22.4 million from a daily average of about 3.3 million.</p><p>Perceptive Capital Solutions (PCSC), a special-purpose acquisition company, and biotech firm Freenome said Friday that they have agreed to form a business combination.</p><p>The companies said the deal includes commitments from a group of healthcare investors for a $240 million common equity Private Investment in Public Equity at $10 per share.</p><p>Shares of Perceptive Capital jumped 12% as intraday trading volume climbed to nearly 2.3 million from a daily average of about 3,000.</p><p>Price: 248.34, Change: +58.37, Percent Change: +30.73</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-06 02:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PRAX\">Praxis Precision Medicines</a> (PRAX) reported positive trial results late Thursday of relutrigine to treat patients with SCN2A and SCN8A developmental and epileptic encephalopathies.</p><p>Deutsche Bank adjusted its price target for Praxis shares to $303 from $270 while maintaining its buy rating.</p><p>Praxis shares soared 31% as intraday trading volume surged to over 2.2 million from a daily average of roughly 975,000.</p><p>SoftBank Group is in talks to buy private-equity firm DigitalBridge Group (DBRG), Bloomberg reported Friday, citing people with knowledge of the matter.</p><p>Shares of DigitalBridge surged 39% as intraday trading volume catapulted to over 22.4 million from a daily average of about 3.3 million.</p><p>Perceptive Capital Solutions (PCSC), a special-purpose acquisition company, and biotech firm Freenome said Friday that they have agreed to form a business combination.</p><p>The companies said the deal includes commitments from a group of healthcare investors for a $240 million common equity Private Investment in Public Equity at $10 per share.</p><p>Shares of Perceptive Capital jumped 12% as intraday trading volume climbed to nearly 2.3 million from a daily average of about 3,000.</p><p>Price: 248.34, Change: +58.37, Percent Change: +30.73</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589145988","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589145988","pubTimestamp":1764958329,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Praxis Precision Medicines (PRAX) reported positive trial results late Thursday of relutrigine to treat patients with SCN2A and SCN8A developmental and epileptic encephalopathies.Deutsche Bank adjuste","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","DBRG":"DigitalBridge Group, Inc.","BK4233":"房地产运营公司","BK4135":"资产管理与托管银行","PRAX":"Praxis Precision Medicines, Inc.","PCSC":"Perceptive Capital Solutions Corp.","BK4205":"房地产经营公司","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4160":"多样化房地产投资信托v"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRAX":1,"DBRG":1,"PCSC":1},"content_text":"Praxis Precision Medicines (PRAX) reported positive trial results late Thursday of relutrigine to treat patients with SCN2A and SCN8A developmental and epileptic encephalopathies.Deutsche Bank adjusted its price target for Praxis shares to $303 from $270 while maintaining its buy rating.Praxis shares soared 31% as intraday trading volume surged to over 2.2 million from a daily average of roughly 975,000.SoftBank Group is in talks to buy private-equity firm DigitalBridge Group (DBRG), Bloomberg reported Friday, citing people with knowledge of the matter.Shares of DigitalBridge surged 39% as intraday trading volume catapulted to over 22.4 million from a daily average of about 3.3 million.Perceptive Capital Solutions (PCSC), a special-purpose acquisition company, and biotech firm Freenome said Friday that they have agreed to form a business combination.The companies said the deal includes commitments from a group of healthcare investors for a $240 million common equity Private Investment in Public Equity at $10 per share.Shares of Perceptive Capital jumped 12% as intraday trading volume climbed to nearly 2.3 million from a daily average of about 3,000.Price: 248.34, Change: +58.37, Percent Change: +30.73","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589145988","isCrawlerRequest":true}